Vyscoxa Suspension
Product Images NDC 15370-501

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Vyscoxa (NDC 15370-501). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Carwin Pharmaceutical Associates, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Celebrex 01)

Chemical structure of celecoxib, illustrating its molecular components including sulfonamide and trifluoromethyl groups attached to a pyrazole ring system, as represented in the image for VYSCOXA oral suspension by Carwin Pharmaceutical Associates.*

FDA Label Image

Principal Display Panel (mg Bottle Label)

Label for VYSCOXA (celecoxib) oral suspension, 10 mg/mL, by Carwin Pharmaceutical Associates, LLC. The label includes dosage strength, volume (16 fl. oz./473 mL), storage instructions, pharmacist dispensing guidance, and warnings. Barcodes and the National Drug Code (NDC 15370-501-16) are present, along with manufacturer details and a note to dispense the accompanying medication guide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.